In a live virtual event, Thomas C. Krivak, MD, reviewed the key studies of PARP inhibitor and bevacizumab maintenance in ...

Trop-2 is a glycoprotein involved in cellular signal transduction and is differentially overexpressed relative to normal tissue in a variety of human adenocarcinomas, including endometrioid ...

Friday, Oct. 24, 2014. (AP Photo/Pablo Martinez Monsivais, File) Updated [hour]:[minute] [AMPM] [timezone], [monthFull] [day], [year] A common blood test may miss ovarian cancer in some Black and ...

Malignant WAT occurring in the ovary is exceptionally uncommon ... indicated a malignant tumor with necrotic areas suggestive of poorly differentiated carcinoma. The patient subsequently underwent a ...

All had ECOG performance status of 0 (28.1%) or 1 (71.9%). Nearly two-thirds (62.5%) had endometrioid adenocarcinoma, and 25% had received at least two prior therapies. All women had disease ...

Informed consent was obtained from all participants involved in the study. The proband of Family II was a 53-year-old woman who was diagnosed with endometrioid adenocarcinoma and underwent total ...

More than half of all ovarian cancers are serous carcinomas. Clear-cell carcinoma, mucinous carcinoma and endometrioid carcinoma each make up 6 to 10 percent of ovarian cancers. High-grade serous ...